JAGUAR HEALTH INC (JAGX) Stock Cash Flow
NASDAQ:JAGX - Nasdaq - US47010C8881 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -40.74M | -39.03M | -41.87M | -49.08M | -52.60M | |||
| Depreciation Amortization | 1.88M | 1.90M | 2.01M | 1.98M | 1.72M | |||
| Income Taxes - Deferred | N/A | N/A | N/A | N/A | N/A | |||
| Change In Working Capital | -1.54M | -3.01M | -11.10M | -4.43M | 2.27M | |||
| Interest Paid | 11.00K | 14.00K | 35.00K | 23.00K | 28.00K | |||
| Other non cash items | 10.75M | 10.76M | 17.71M | 18.42M | 13.64M | |||
| OPERATING CASH FLOW | -29.65M | -29.38M | -33.24M | -33.10M | -34.97M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | -231.00K | 0.00 | -1.68M | -6.00K | |||
| Other Investing Activity | N/A | N/A | N/A | N/A | N/A | |||
| INVESTING CASH FLOW | N/A | -231.00K | 0.00 | -1.68M | -6.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 2.84M | -608.00K | -100.00K | 3.88M | 9.05M | |||
| Stock Issued/Repurchased | 21.18M | 31.91M | 33.95M | 20.46M | 35.62M | |||
| Other Financing Activity | -116.00K | -100.00K | 380.00K | -1.16M | -731.00K | |||
| FINANCING CASH FLOW | 23.90M | 31.20M | 34.23M | 23.18M | 43.94M | |||
| Exchange Rate Effect | 1.00K | -54.00K | 15.00K | 16.00K | N/A | |||
| CHANGE IN CASH | -5.98M | 1.53M | 1.00M | -11.58M | 8.96M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -29.65M | -29.38M | -33.24M | -33.10M | -34.97M | |||
| Capital Expenditure | N/A | -231.00K | 0.00 | -1.68M | -6.00K | |||
| FREE CASH FLOW | -29.88M | -29.61M | -33.24M | -34.78M | -34.98M | |||
All data in USD